CanBas Co

CanBas Co ROA

The Return on Assets (ROA) of CanBas Co (4575.T) as of Oct 19, 2026 is -73.66 %. In the previous year, Return on Assets (ROA) was -37.93 % — a change of 94.18% (lower).

ROA

-73.66 %

YoY

94.18%

Last updated:

In 2026, CanBas Co's return on assets (ROA) was -73.66 %, a 94.18% increase from the -37.93 % ROA in the previous year.

The CanBas Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2019
-52.12 JPY
Jan 1, 2020
-45.34 JPY
Jan 1, 2021
-40.99 JPY
Jan 1, 2022
-108.20 JPY
Jan 1, 2023
-59.64 JPY
Jan 1, 2024
-49.69 JPY
Jan 1, 2025
-37.93 JPY
Jan 1, 2026
-73.66 JPY
The CanBas Co ROA history
YEARROAYoY
-73.66 %+94.18%
-37.93 %-23.67%
-49.69 %-16.68%
-59.64 %-44.88%
-108.20 %+163.99%
-40.99 %-9.60%
-45.34 %-13.00%
-52.12 %-43.36%
-92.01 %+117.86%
-42.23 %-1.56%
-42.90 %+60.36%
-26.75 %-71.72%
-94.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CanBas Co Stock analysis

What does CanBas Co do? CanBas Co Ltd is a biotechnology company based in Numazu-shi, Japan, operating within the healthcare sector. The company has a small team of 12 employees and went public on September 17, 2009, with its ticker listed as 4575.T and ISIN JP3244570002. Its primary focus is on anticancer drug discovery research, which includes developing drug discovery concepts, selecting candidate compounds through method-based approaches, conducting simple animal studies, and analyzing basic data on anticancer drug candidates entering development. Additionally, CanBas engages in early clinical development activities, such as preclinical studies required before submitting applications for clinical trials and conducting the initial phases of clinical trials. The company maintains a website at https://www.canbas.co.jp/ for further information. CanBas operates as a private entity with a minimal workforce, emphasizing research and development in the early stages of anticancer drug development. It does not provide details on specific products, acquisitions, or financial figures beyond its IPO date and employee count. The company's headquarters are located in Numazu-shi, Shizuoka Prefecture, Japan, and it is listed on the Tokyo Stock Exchange. Its operations are centered around foundational research in oncology, aiming to contribute to the discovery and development of new anticancer treatments. CanBas Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding CanBas Co's Return on Assets (ROA)

CanBas Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing CanBas Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider CanBas Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in CanBas Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about CanBas Co stock

Return on Assets (ROA) of CanBas Co is -73.66 % in 2026.

Return on Assets (ROA) of CanBas Co changed from -37.93 % to -73.66 %, representing a 94.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) CanBas Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s CanBas Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CanBas Co

All Key Metrics — CanBas Co